Discover

AMGN
Amgen Inc.
361.33
1 x 361.89
1 x 360.89
bid
ask
-
0.79
0.22%
1 @ 07:06 AM
362.88 +1.55 (0.43%)
Ytd10.39%
1y24.37%
357.89
day range
364.00
269.77
52 week range
391.29
Open362.10Prev Close362.12Low357.89High364.00Mkt Cap195.01B
Vol1.95MAvg Vol2.75MEPS14.38P/E25.13Forward P/E15.40
Beta0.42Short Ratio4.42Inst. Own85.21%Dividend10.08Div Yield2.78
Ex Div Date05-15Earning08-0450-d Avg340.81200-d Avg334.841yr Est352.77

AMGN News

Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel
reuters.com
Judge blocks Colorado's first-of-its-kind price cap on Amgen's Enbrel

A federal judge on Wednesday blocked Colorado ​from capping the price of Amgen's blockbuster arthrit

Amgen or Biogen: Which Biotech Stock Appears Better Poised?
zacks.com
Amgen or Biogen: Which Biotech Stock Appears Better Poised?

AMGN stands out compared to Biogen given its broader product portfolio, pipeline depth and steadier

Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
zacks.com
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage

Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified wa

Micron, Palo Alto, Apple And A Health Care Stock On CNBC’s ‘Final Trades’
benzinga.com
Micron, Palo Alto, Apple And A Health Care Stock On CNBC’s ‘Final Trades’

CNBC Final trades: Lebenthal picks Micron, Snipe chooses Palo Alto, Brown expects Apple's good s

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
zacks.com
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth expl

Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now.
fool.com
Alphabet Just Joined the Dow Jones Industrial Average. 3 Dow Dividend Stocks to Buy Now.

Cisco Systems is on a roll with its AI-powered platform. Coca-Cola saw volume growth in each of its

Medical journal retracts paper on Amgen's Tavneos drug trial after FDA findings
reuters.com
Medical journal retracts paper on Amgen's Tavneos drug trial after FDA findings

The New England Journal of Medicine on Monday retracted an article on a pivotal clinical trial that

Apollo To Drive Quantinuum Revenue Growth Of 128% Until 2031, Say Bullish Analysts
benzinga.com
Apollo To Drive Quantinuum Revenue Growth Of 128% Until 2031, Say Bullish Analysts

Shares of Quantinuum slide after rallying since IPO. Analysts weigh in.

Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease
benzinga.com
Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease

The U.S. Food and Drug Administration on Friday approved Viridian Therapeutics Inc.'s (NASDAQ:VRDN)

Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease
benzinga.com
Viridian Secures First FDA Approval, Sets Up Challenge To Amgen's Tepezza For Thyroid Eye Disease

FDA approves Viridian Therapeutics' Lumvoa for thyroid eye disease. Immediate commercial launch

European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked
wsj.com
European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked

The committee is recommending that no new patients start treatment with Tavneos and that existing pa

EMA recommends revoking marketing authorisation for Amgen's rare-disease drug
reuters.com
EMA recommends revoking marketing authorisation for Amgen's rare-disease drug

The European Medicines Agency on ‌Friday recommended revoking the marketing authorisation for Amgen'

Less Volume, More Premium: Post-Ozempic Economics Are Killing The Quantity Model
benzinga.com
Less Volume, More Premium: Post-Ozempic Economics Are Killing The Quantity Model

As millions take GLP-1 drugs, packaged food giants face declining volumes while protein brands and s

W.P. Carey To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
benzinga.com
W.P. Carey To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday

Top analysts changed ratings on top names, including Sunrun, enGene Therapeutics, Camp4 Therapeutics

benzinga.com
Mizuho Maintains Neutral on Amgen, Raises Price Target to $303

Mizuho analyst Salim Syed maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price targe

benzinga.com
Morgan Stanley Maintains Equal-Weight on Amgen, Raises Price Target to $340

Morgan Stanley analyst Terence Flynn maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises

benzinga.com
Reported June 1, 2026: European Commission Approves Amgen's IMDYLLTRA For The Treatment Of Extensive

Approval Based Upon Phase 3 DeLLphi-304 Trial Demonstrating 40% Reduction in Risk of Death with IMDY

benzinga.com
Amgen Ventures Invests In Ember LifeSciences; Terms Undisclosed

Ember LifeSciences, Inc., ("Ember") a leading provider of revolutionary cold chain technolog

10 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com
10 Health Care Stocks With Whale Alerts In Today's Session

Amgen Japanese Partner Urges Caution On Tavneos Use
benzinga.com
Amgen Japanese Partner Urges Caution On Tavneos Use

Amgen partner Kissei advised doctors to avoid new Tavneos use in Japan after FDA liver injury warnin

benzinga.com
'20 People in Japan Died After Taking Amgen Drug' - Wall Street Journal

https://www.wsj.com/health/pharma/20-people-in-japan-died-after-taking-amgen-drug-40edaefd?mod=Searc

benzinga.com
Piper Sandler Maintains Overweight on Amgen, Lowers Price Target to $427

Piper Sandler analyst David Amsellem maintains Amgen (NASDAQ:AMGN) with a Overweight and lowers t

Florida Rep. Maria Elvira Salazar Bought Over $81K Worth of Carrier Global Stock: Here's What You Should Know
benzinga.com
Florida Rep. Maria Elvira Salazar Bought Over $81K Worth of Carrier Global Stock: Here's What You Sh

RFK Jr. Wants Fewer Americans On Antidepressants — Here's Why The Debate Is Exploding
benzinga.com
RFK Jr. Wants Fewer Americans On Antidepressants — Here's Why The Debate Is Exploding

U.S. officials discussed possible SSRI restrictions as RFK Jr. unveiled a broader push to reduce ant

benzinga.com
Guggenheim Maintains Neutral on Amgen, Lowers Price Target to $340

Guggenheim analyst Vamil Divan maintains Amgen (NASDAQ:AMGN) with a Neutral and lowers the price

benzinga.com
Amgen Plans Additional $300M Investment In Its U.S. Production Network

Amgen (NASDAQ: AMGN) today announced plans to invest an additional $300 million in its U.S. manufact

benzinga.com
Truist Securities Maintains Hold on Amgen, Raises Price Target to $327

Truist Securities analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Hold and raises the

Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU
benzinga.com
Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU

U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on

Transcript: Amgen Q1 2026 Earnings Conference Call
benzinga.com
Transcript: Amgen Q1 2026 Earnings Conference Call

benzinga.com
Update: Amgen Raises FY2026 Adj EPS Guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 Est; Rais

Amgen (NASDAQ:AMGN) raises FY2026 Adj EPS guidance from $21.60-$23.00 to $21.70-$23.10 vs $22.33 ana

benzinga.com
Amgen Raises FY2026 GAAP EPS Guidance from $15.45-$16.94 to $15.62-$17.10 vs $15.18 Est

Amgen (NASDAQ:AMGN) raises FY2026 GAAP EPS guidance from $15.45-$16.94 to $15.62-$17.10 vs $15.18 an

benzinga.com
Amgen Q1 Adj. EPS $5.15 Beats $4.76 Estimate, Sales $8.618B Beat $8.579B Estimate

Amgen (NASDAQ:AMGN) reported quarterly earnings of $5.15 per share which beat the analyst consensus

Stock Market Today: Dow Jones Roars As Industrials Rescue Wall Street From Meta-Led Tech Slide
benzinga.com
Stock Market Today: Dow Jones Roars As Industrials Rescue Wall Street From Meta-Led Tech Slide

A sharp rotation gripped Wall Street at midday Thursday as blue-chip industrials and healthcare powe

Earnings Scheduled For April 30, 2026
benzinga.com
Earnings Scheduled For April 30, 2026

Elizabeth Warren Calls Trump's '600%' Drug Price Claim Mathematically Impossible: 'His Promise Is As Empty As…'
benzinga.com
Elizabeth Warren Calls Trump's '600%' Drug Price Claim Mathematically Impossible: 'His Promise Is As

Sen. Warren challenges Trump's 600% TrumpRx drug price claim using a glass of water.

FDA Review Panel Challenges Amgen's Tavneos Approval On Efficacy, Data Grounds
benzinga.com
FDA Review Panel Challenges Amgen's Tavneos Approval On Efficacy, Data Grounds

FDA unit proposes Amgen's Tavneos withdrawal citing manipulated trial data, lack of efficacy evi

benzinga.com
Reported April 27, 2026: Amgen Faces FDA Move To Withdraw TAVNEOS NDA Approval Over Alleged Data Man

https://www.fda.gov/media/192160/download?attachment

The Dow Jones Earnings Showdown: 11 Blue‑Chips Step Up This Week
benzinga.com
The Dow Jones Earnings Showdown: 11 Blue‑Chips Step Up This Week

It's a big week for the Dow Jones Industrial Average with 11 of the 30 components reporting earn

Congresswoman Discloses Hundreds Of Thousands In Stock Trades, Here's What She Bought
benzinga.com
Congresswoman Discloses Hundreds Of Thousands In Stock Trades, Here's What She Bought

A member of Congress recently bought hundreds of thousands of dollars in stocks, marking her first t

Congressional Trading Report: Rep. Maria Elvira Salazar Bought Over $221K In Amgen Stock
benzinga.com
Congressional Trading Report: Rep. Maria Elvira Salazar Bought Over $221K In Amgen Stock

benzinga.com
Canaccord Genuity Initiates Coverage On Amgen with Hold Rating, Announces Price Target of $366

Canaccord Genuity analyst Gary Nachman initiates coverage on Amgen (NASDAQ:AMGN) with a Hold rati

benzinga.com
Amazon One Medical Introduces Weight Management Program With Upfront GLP-1 Medication Costs

https://www.aboutamazon.com/news/retail/amazon-glp1-management-program

benzinga.com
$1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today

benzinga.com
Guggenheim Maintains Neutral on Amgen, Raises Price Target to $351

Guggenheim analyst Vamil Divan maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price

benzinga.com
Cantor Fitzgerald Reiterates Neutral on Amgen, Maintains $350 Price Target

Cantor Fitzgerald analyst Carter Gould reiterates Amgen (NASDAQ:AMGN) with a Neutral and maintain

Why Is Viridian Therapeutics Stock Sinking Monday?
benzinga.com
Why Is Viridian Therapeutics Stock Sinking Monday?

Viridian shares fall after Amgen TEPEZZA Phase 3 data shows stronger efficacy, raising concerns over

Amgen Posts 77% Response In Thyroid Eye Disease Study
benzinga.com
Amgen Posts 77% Response In Thyroid Eye Disease Study

Amgen shares fall despite Phase 3 TEPEZZA OBI data showing 77% response rate and proptosis reduction

benzinga.com
Amgen Announces Phase 3 Study Of TEPEZZA Meets Primary Endpoint In Moderate-To-Severe Active Thyroid

Amgen (NASDAQ: AMGN) today announced positive topline results from a Phase 3 trial of TEPEZZA (tepro

benzinga.com
If You Invested $100 In Amgen Stock 15 Years Ago, You Would Have This Much Today

Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report
benzinga.com
Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report

According to a Bloomberg report, Trump may impose 100% tariffs on drugmakers without pricing deals,